Recent data demonstrate a possible association between double anti-PAD3 and PAD-4 positivity with both ILD and more erosive disease and the authors have hypothesized that such patients might have anti-PAD3/4XR positivity (112). This evidence concerns the gene PADI4 and interstitial lung disease.